Insights

McMillan Shakespeare (ASX:MMS) share price plummets 9% despite 2500% rise in NPAT

Investors may be asking themselves, “To own, or not to own? That is the question.”
The post McMillan Shakespeare (ASX:MMS) share price plummets 9% despite 2500% rise in NPAT appeared first on The Motley Fool Australia. –

The McMillan Shakespeare Limited (ASX: MMS) share price is in freefall after the release of the company’s full-year results for FY21.

At the time of writing, shares in the salary packaging and asset management provider are trading for $12.18 – down 8.97%. The S&P/ASX 200 Index (ASX: XJO), meanwhile, is 0.18% higher.

Let’s take a closer look.

McMillan Shakespeare share price slumps despite dividend almost doubling

Revenue from continuing operations rose 10.2% on the prior corresponding period (pcp) to $544 million.

Earnings before interest, taxes, depreciation, and amortisation (EBITDA) of $131 million – up 31.4% on the pcp.
Basic earnings per share (EPS) rocketed more than 4,800% on the pcp to 78.9 cents.
Net cash inflow of $66.6 million for the financial year.
Full-year dividend of 61.3 cents per share (final dividend of 31.1 cents and interim dividend of 30.2 cents), fully franked. It’s an 80.3% increase on the pcp and represents a yield of 5.05% on the current share price.

What happened in FY21 for McMillan Shakespeare?

The biggest story in the world, and one that had a material impact on the McMillan Shakespeare share price in FY21, was the coronavirus pandemic.

The company talked about the effect of the pandemic on its finances in its annual report. To quote:

In response to the pandemic, we instituted a wage freeze for FY21 and no bonuses relating to FY20 were paid. Additionally, we extended senior debt maturities and non-essential spending was restricted. The Australian Government JobKeeper funding received ($7.3 million after-tax) in FY21 enabled the retention of our employees despite the challenges of COVID-19 and the negative impacts on our financial performance compared to FY19. The business by period end had returned to around 90% of its pre-pandemic performance, equating to approximately 80% in the absence of JobKeeper.

What’s next for McMillan Shakespeare?

McMillan Shakespeare said it expects the uncertain trading environment of the pandemic to continue in FY22.

“We expect the abnormal trading conditions that characterised FY21 to continue throughout FY22, in particular given the ongoing response of governments to the global pandemic, and motor vehicle supply constraints,” the company said.

“Our strategic focus in FY22 centres on growth and efficiency across our businesses…”

McMillan Shakespeare share price snapshot

Despite today’s massive correction, the McMillan Shakespeare share price has increased 25% over 12 months. It has dropped just over 1% year-to-date, however.

McMillan Shakespeare has a market capitalisation of around $1 billion.

The post McMillan Shakespeare (ASX:MMS) share price plummets 9% despite 2500% rise in NPAT appeared first on The Motley Fool Australia.

Should you invest $1,000 in McMillan Shakespeare right now?

Before you consider McMillan Shakespeare, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and McMillan Shakespeare wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Pepper Money (ASX:PPM) share price jumps 7% on ‘milestone after milestone’
Bendigo Bank (ASX:BEN) share price outperforming amid ‘sustainability first’
Why HUB24, MNF, Nanosonics, & Uniti shares are surging higher

ReadyTech (ASX:RDY) share price soars 7% on $50 million revenue
Event (ASX: EVT) share price soars 10% to a 52-week high

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!